Stay updated on XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial
Sign up to get notified when there's something new on the XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial page.
Latest updates to the XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial page
- Check2 days agoChange DetectedLocations list updated to add new sites (e.g., Hospital Universitario Fundación Jiménez Díaz in Madrid; Instituto de Neurologia Cognitiva (INECO) in Buenos Aires; Duke University Clinic in Durham, NC) and remove others, with the total number of locations now shown as 86.SummaryDifference2%
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; there are no visible changes to page content or layout.SummaryDifference0.0%
- Check38 days agoChange DetectedRemoval of a generic government funding status notice occurred; core study details (title, NCT number, locations, eligibility criteria, and outcomes) remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check45 days agoChange DetectedThe 'Last Update Posted' field has been replaced with 'Last Update Posted (Estimated)', introducing an estimated timestamp for the last update.SummaryDifference0.0%
- Check52 days agoChange DetectedDifference1%
- Check66 days agoChange DetectedMajor updates to study recruitment locations and status; total locations increased from 67 to 69, new locations added internationally, and status/timeframe fields updated (Withdrawn, Last Update Posted (Estimated)).SummaryDifference2%
Stay in the know with updates to XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XEN1101 vs Placebo in Focal-Onset Seizures Clinical Trial page.